Search

Filters
Clear All
  • 2
  • 9

Phase

  • 1
  • 2
  • 1
  • 4
  • 3
  • 11

Found 11 site-public-contact trials

A listing of site-public-contact medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

T
Tarah Ballinger, MD
18 years - 100 years
All genders
What is the purpose of this study? The purpose of this study is to examine how a multimodality (having or using a variety of methods to do something) exercise intervention may improve survival, function, and quality of life in participants with advanced lung cancer. Interested in participating? For more information about this …
H
Huda Salman
18 years - 100 years
All genders
What is the purpose of this study?This study is designed as a single arm open label traditional Phase I, 3+3, study of CD4-redirected chimeric antigen receptor engineered T-cells (CD4CAR) in patients with relapsed or refractory AML. the study will evaluate safety in this patient population and also the presence of …
T
Tarah Ballinger, MD
18 years - 100 years
All genders
Why is this study being done?The purpose of this study is to test a program for Black women and their families at risk of breast cancer to have access to community health advocates that will help them understand their risk of developing breast cancer, navigate screenings, and access additional ways …
L
Lisa Landrum, MD, PhD, MS
18 years - 100 years
Female
Phase 3
What is the purpose of this study?The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer who have received prior treatment with platinum-based chemotherapy and immunotherapy, versus the treatment of physician's choice (TPC).Interested in participating? For more …
T
Tareq Salous
18 years - 100 years
All genders
Phase 2/3
What is this study about?This phase II/III trial examines whether patients who have undergone surgical removal of bladder, but require an additional treatment called immunotherapy to help prevent their bladder cancer from coming back, can be identified by a blood test. Many types of tumors tend to lose cells or …
L
Lisa Landrum, MD, PhD, MS
18 years - 100 years
Female
Phase 1/2
What is the purpose of  this study?This phase Ib/II trial tests the safety, side effects, best dose, and effectiveness of the combination of ipatasertib with megestrol acetate to megestrol acetate alone in patients with endometrial cancer that has come back (recurrent) or has spread to other places in the body …
N
Nawal Kassem
18 years - 100 years
All genders
Phase 3
What is the purpose of this study?The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the …
S
Samantha Armstrong
18 years - 100 years
All genders
Phase 3
What is the purpose of this study?This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dedifferentiated Liposarcoma) and LMS (Leiomyosarcoma) patients as measured by disease free survival. Interested in participating? For more …
S
Samantha Armstrong
18 years - 100 years
All genders
Phase 2
What is the purpose of this study?This phase II trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with undifferentiated pleomorphic sarcoma (UPS) or a related poorly differentiated sarcoma that has spread from where it first started to other places in the …
R
Rita Assi
18 years - 100 years
All genders
Phase 3
What is the purpose of this study?The purpose of this study is to evaluate the efficacy of glofitamab monotherapy compared with an investigator's choice of either rituximab plus bendamustine (BR), or lenalidomide with rituximab (R-Len) in patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL). Interested in participating? For more …
1 - 10 of 11